从病理学到材料科学与工程:利用粉状物状态用于生物技术应用
Lucas B Fallot1,2, Chandramouli Natarajan1, Carol A Anderson1,2
1Department of Chemical and Biological Science and Engineering, United States Military Academy, West Point, New York 10996, United States.
ACS applied materials & interfaces
|November 10, 2025
概括
蛋白质错误折叠导致像阿尔茨海默氏症这样的疾病. 本综述探讨了用于新生物技术的粉样结构,从药物输送到生物电子,为社会提供好处.
科学领域:
- 生物化学和材料科学 材料科学
- 生物技术和纳米技术
背景情况:
- 蛋白质错误折叠和聚合是60多种疾病的核心,包括阿尔茨海默病和帕金森病.
- 蛋白质从无序的单体过渡到有序的粉样纤维,具有广泛的β片结构.
- 功能性粉样蛋白还在整个生物体的生理过程中发挥作用.
研究的目的:
- 审查管理粉样蛋白形成的原则.
- 探索利用粉样蛋白的生物物理性质和模板设计能力,用于生物技术应用.
- 讨论基于粉素的材料在不同领域的潜力.
主要方法:
- 对有关粉样蛋白形成和功能性粉样蛋白的现有文献的综述.
- 对粉样结构的生物物理性质和模板能力的分析.
- 识别和分类潜在的生物技术应用.
主要成果:
- 粉样蛋白的形成涉及到过渡到高度有序的纤维状结构.
- 粉样蛋白具有独特的生物物理特性和模板设计能力.
- 不同的应用包括气凝,水凝,药物输送,组织工程,抗菌剂,催化剂和生物电子.
结论:
- 粉样结构为开发新生物材料提供了重大潜力.
- 基于粉样蛋白的生物技术的成功实施需要解决当前的挑战.
- 未来的研究可以从粉样蛋白的应用中获得广泛的社会利益.
相关概念视频
03:03Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
03:03Amyloid Fibrils
6.3K
6.3K